Citations

Showing 10 of 108119 citations.

Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from CALGB 89803 (Alliance)
Lee, Seohyuk , Zhang, Sui , Ou, Fang‐Shu , Bainter, Tiffany M., Niedzwiecki, Donna , Whittom, Renaud , Hantel, Alexander, Benson, Al B. , Atienza, Daniel, Kindler, Hedy L. , Gross, Cary P. , Irwin, Melinda L. , Meyerhardt, Jeffrey A. , Fuchs, Charles S. , Ou, Fang-Shu , Kindler, Hedy , Meyerhardt, Jeffrey A , Niedzwiecki, Donna , Ma, Chao , Saltz, Leonard B. , Mayer, Robert J.

Mayo Clinic

The Oncologist | January 13, 2022 | Volume: 27 | Issue: 6 | Pages: e494-e505

10.1093/oncolo/oyab070 | PMID 35641198 Get It

Abstract Background Limited and conflicting findings have been reported regarding the association between social support and colorectal cancer (CRC) outcomes. We sought to assess the influences of marital status and living arrangement on survival outcomes among patients with stage III colon cancer. Patients and Methods We conducted a secondary analysis of 1082 patients with stage III colon cancer prospectively followed in the CALGB 89803 randomized adjuvant chemotherapy trial. Marital status and living arrangement were both self-reported at the time of enrollment as, respectively, married, divorced, separated, widowed, or never-married, and living alone, with a spouse or partner, with other family, in a nursing home, or other. Results Over a median follow-up of 7.6 years, divorced/separated/widowed patients experienced worse outcomes relative to those married regarding disease free-survival (DFS) (hazards ratio (HR), 1.44 (95% CI, 1.14-1.81); P =.002), recurrence-free survival (RFS) (HR, 1.35 (95% CI, 1.05-1.73); P = .02), and overall survival (OS) (HR, 1.40 (95% CI, 1.08-1.82); P =.01); outcomes were not significantly different for never-married patients. Compared to patients living with a spouse/partner, those living with other family experienced a DFS of 1.47 (95% CI, 1.02-2.11; P = .04), RFS of 1.34 (95% CI, 0.91-1.98; P = .14), and OS of 1.50 (95% CI, 1.00-2.25; P =.05); patients living alone did not experience significantly different outcomes. Conclusion Among patients with stage III colon cancer who received uniform treatment and follow-up within a nationwide randomized clinical trial, being divorced/separated/widowed and living with other family were significantly associated with greater colon cancer mortality. Interventions enhancing social support services may be clinically relevant for this patient population. Trial Registration ClinicalTrials.gov Identifier: NCT00003835
Solid Organ Transplantation From SARS-CoV-2–infected Donors to Uninfected Recipients: A Single-center Experience
Jayasekera, Channa R., Vikram, Holenarasipur R., Rifat, Zeeshan, Wagler, Josiah, Okubo, Keita, Braaksma, Brandon R., Harbell, Jack W., Jadlowiec, Caroline C., Katariya, Nitin N., Mathur, Amit K., Moss, Adyr, Reddy, K. Sudhakar, Singer, Andrew, Orenstein, Robert, Saling, Christopher F., Seville, Maria T., Mour, Girish K., Vargas, Hugo E., Byrne, Thomas J., Hewitt, Winston R., Aqel, Bashar A., Vargas, Hugo E. , Vikram, Holenarasipur R. , Katariya, Nitin , Vikram, Holenarasipur R. , Vargas, Hugo E , Katariya, Nitin N , Jayasekera, Channa R., Rifat, Zeeshan, Wagler, Josiah, Okubo, Keita, Braaksma, Brandon R., Harbell, Jack W., Jadlowiec, Caroline C., Mathur, Amit K., Moss, Adyr, Reddy, K. Sudhakar, Singer, Andrew, Orenstein, Robert, Saling, Christopher F., Seville, Maria T., Mour, Girish K., Byrne, Thomas J., Hewitt, Winston R., Aqel, Bashar A., Okubo, Keita

Mayo Clinic

Transplantation Direct | January 13, 2022 | Volume: 8 | Issue: 2 | Pages: e1286

10.1097/txd.0000000000001286 | PMID 35047665 Get It

Background. The risk of donor-derived severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in solid organ (heart, lung, liver, kidney, pancreas, and intestine) transplant recipients is poorly understood. Since hematogenous transmission of SARS-CoV-2 has not been documented to date, nonlung solid organs might be suitable for transplantation since they likely portend a low risk of viral transmission. Methods. Abdominal solid organs from SARS-CoV-2–infected donors were transplanted into uninfected recipients. Results. Between April 18, 2021, and October 30, 2021, we performed transplants of 2 livers, 1 simultaneous liver and kidney, 1 kidney, and 1 simultaneous kidney and pancreas from SARS-CoV-2–infected donors into 5 uninfected recipients. None of the recipients developed SARS-CoV-2 infection or coronavirus disease 2019, and when tested, allograft biopsies showed no evidence of SARS-CoV-2 RNA. Conclusions. Transplanting nonlung organs from SARS-CoV-2–infected donors into uninfected recipients demonstrated no evidence of virus transmission.
Death With Function and Graft Failure After Kidney Transplantation: Risk Factors at Baseline Suggest New Approaches to Management
Merzkani, Massini A., Bentall, Andrew J., Smith, Byron H., Lopez, Xiomara Benavides, D’Costa, Matthew R., Park, Walter D., Kremers, Walter K., Issa, Naim, Rule, Andrew D., Chakkera, Harini, Reddy, Kunam, Khamash, Hasan, Wadei, Hani M., Mai, Martin, Alexander, Mariam P., Amer, Hatem, Kukla, Aleksandra, Ters, Mireille El, Schinstock, Carrie A., Gandhi, Manish J., Heilman, Raymond, Stegall, Mark D., Kremers, Walter K. , Chakkera, Harini A. , Wadei, Hani M. , D’Costa, Matthew R. , Benavides Lopez, Xiomara, El Ters, Mireille, D'Costa, Matthew , Chakkera, Harini A , Wadei, Hani M , Kremers, Walter K , Merzkani, Massini A., Bentall, Andrew J., Smith, Byron H., Lopez, Xiomara Benavides, Park, Walter D., Issa, Naim, Rule, Andrew D., Reddy, Kunam, Khamash, Hasan, Mai, Martin, Alexander, Mariam P., Amer, Hatem, Kukla, Aleksandra, Ters, Mireille El, Schinstock, Carrie A., Gandhi, Manish J., Heilman, Raymond, Stegall, Mark D.

Mayo Clinic

Transplantation Direct | January 13, 2022 | Volume: 8 | Issue: 2 | Pages: e1273

10.1097/txd.0000000000001273 | PMID 35047660 Get It

Background. Improving both patient and graft survival after kidney transplantation are major unmet needs. The goal of this study was to assess risk factors for specific causes of graft loss to determine to what extent patients who develop either death with a functioning graft (DWFG) or graft failure (GF) have similar baseline risk factors for graft loss. Methods. We retrospectively studied all solitary renal transplants performed between January 1, 2006, and December 31, 2018, at 3 centers and determined the specific causes of DWFG and GF. We examined outcomes in different subgroups using competing risk estimates and cause-specific Cox models. Results. Of the 5752 kidney transplants, graft loss occurred in 21.6% (1244) patients, including 12.0% (691) DWFG and 9.6% (553) GF. DWFG was most commonly due to malignancy (20.0%), infection (19.7%), cardiac disease (12.6%) with risk factors of older age and pretransplant dialysis, and diabetes as the cause of renal failure. For GF, alloimmunity (38.7%), glomerular diseases (18.6%), and tubular injury (13.9%) were the major causes. Competing risk incidence models identified diabetes and older recipients with higher rates of both DWFG and nonalloimmune GF. Conclusions. These data suggest that at baseline, 2 distinct populations can be identified who are at high risk for renal allograft loss: a younger, nondiabetic patient group who develops GF due to alloimmunity and an older, more commonly diabetic population who develops DWFG and GF due to a mixture of causes—many nonalloimmune. Individualized management is needed to improve long-term renal allograft survival in the latter group.
Targeting Protein Arginine Methyltransferase 5 Suppresses Radiation-induced Neuroendocrine Differentiation and Sensitizes Prostate Cancer Cells to Radiation
Owens, Jake L. , Beketova, Elena , Liu, Sheng, Shen, Qi, Pawar, Jogendra Singh , Asberry, Andrew M. , Yang, Jie, Deng, Xuehong, Elzey, Bennett D., Ratliff, Timothy L. , Cheng, Liang , Choo, Richard, Citrin, Deborah E., Polascik, Thomas J., Wang, Bangchen, Huang, Jiaoti, Li, Chenglong, Hu, Chang-Deng, Citrin, Deborah E. , Wang, Bangchen , Shen, Qi , Wan, Jun , Cheng, Liang , Wang, Bangchen , Owens, Jake L. , Beketova, Elena , Liu, Sheng, Shen, Qi, Pawar, Jogendra Singh , Asberry, Andrew M. , Yang, Jie, Deng, Xuehong, Elzey, Bennett D., Ratliff, Timothy L. , Choo, Richard, Polascik, Thomas J., Wang, Bangchen, Huang, Jiaoti, Li, Chenglong, Hu, Chang-Deng

Mayo Clinic

Molecular Cancer Therapeutics | January 13, 2022 | Volume: 21 | Issue: 3 | Pages: 448-459

10.1158/1535-7163.mct-21-0103 | PMID 35027481 Get It

Abstract Prostate cancer remains the second leading cause of cancer death among American men. Radiotherapy is a potentially curative treatment for localized prostate cancer, and failure to control localized disease contributes to the majority of prostate cancer deaths. Neuroendocrine differentiation (NED) in prostate cancer, a process by which prostate adenocarcinoma cells transdifferentiate into neuroendocrine-like (NE-like) cells, is an emerging mechanism of resistance to cancer therapies and contributes to disease progression. NED also occurs in response to treatment to promote the development of treatment-induced neuroendocrine prostate cancer (NEPC), a highly aggressive and terminal stage disease. We previously demonstrated that by mimicking clinical radiotherapy protocol, fractionated ionizing radiation (FIR) induces prostate cancer cells to undergo NED in vitro and in vivo. Here, we performed transcriptomic analysis and confirmed that FIR-induced NE-like cells share some features of clinical NEPC, suggesting that FIR-induced NED represents a clinically relevant model. Furthermore, we demonstrated that protein arginine methyltransferase 5 (PRMT5), a master epigenetic regulator of the DNA damage response and a putative oncogene in prostate cancer, along with its cofactors pICln and MEP50, mediate FIR-induced NED. Knockdown of PRMT5, pICln, or MEP50 during FIR-induced NED and sensitized prostate cancer cells to radiation. Significantly, PRMT5 knockdown in prostate cancer xenograft tumors in mice during FIR prevented NED, enhanced tumor killing, significantly reduced and delayed tumor recurrence, and prolonged overall survival. Collectively, our results demonstrate that PRMT5 promotes FIR-induced NED and suggests that targeting PRMT5 may be a novel and effective radiosensitization approach for prostate cancer radiotherapy.
A population‐based study of acute panmyelosis with myelofibrosis in the United States: 2004–2015
McLaughlin, N , Ruan, Gordon , Day, Courtney N. , Harmsen, William S. , Smith, Caleb J. , Binder, Moritz , Gangat, Naseema , Tefferi, Ayalew , Shah, Meera , McLaughlin, Nicole , Tefferi, Ayalew , Shah, Mithun V , Binder, Moritz , Go, Ronald S.

Mayo Clinic

American Journal of Hematology | January 13, 2022 | Volume: 97 | Issue: 4 | Pages: No page available

10.1002/ajh.26467 | PMID 35025125 Get It

Patient Attitudes Toward Acupuncture in the Perioperative Setting
Harbell, Monica W. , Barendrick, Lindsay N., Mi, Lanyu , Quillen, Jaxon , Millstine, Denise , Millstine, Denise M, Harbell, Monica W , Barendrick, Lindsay N.

Mayo Clinic

Journal of Integrative and Complementary Medicine | January 13, 2022 | Volume: 28 | Issue: 4 | Pages: 349-354

10.1089/jicm.2021.0311 | PMID 35426737 Get It

massNet: integrated processing and classification of spatially resolved mass spectrometry data using deep learning for rapid tumor delineation
Abdelmoula, Walid M. , Randall, Elizabeth C., Agar, Jeffrey N. , Wells, William M. , Kapur, Tina , Agar, Nathalie Y.R. , Agar, Nathalie Y R , Stopka, Sylwia A. , Regan, Michael S. , Sarkaria, Jann N.

Mayo Clinic

Bioinformatics | January 13, 2022 | Volume: 38 | Issue: 7 | Pages: 2015-2021

10.1093/bioinformatics/btac032 | PMID 35040929 Get It

Abstract Motivation Mass spectrometry imaging (MSI) provides rich biochemical information in a label-free manner and therefore holds promise to substantially impact current practice in disease diagnosis. However, the complex nature of MSI data poses computational challenges in its analysis. The complexity of the data arises from its large size, high-dimensionality and spectral nonlinearity. Preprocessing, including peak picking, has been used to reduce raw data complexity; however, peak picking is sensitive to parameter selection that, perhaps prematurely, shapes the downstream analysis for tissue classification and ensuing biological interpretation. Results We propose a deep learning model, massNet, that provides the desired qualities of scalability, nonlinearity and speed in MSI data analysis. This deep learning model was used, without prior preprocessing and peak picking, to classify MSI data from a mouse brain harboring a patient-derived tumor. The massNet architecture established automatically learning of predictive features, and automated methods were incorporated to identify peaks with potential for tumor delineation. The model’s performance was assessed using cross-validation, and the results demonstrate higher accuracy and a substantial gain in speed compared to the established classical machine learning method, support vector machine. Availability and implementation https://github.com/wabdelmoula/massNet. The data underlying this article are available in the NIH Common Fund’s National Metabolomics Data Repository (NMDR) Metabolomics Workbench under project id (PR001292) with http://dx.doi.org/10.21228/M8Q70T. Supplementary information Supplementary data are available at Bioinformatics online.
Faculty Opinions recommendation of Association between human papilloma virus infection and malignant sinonasal inverted papilloma.
Lal, Devyani , Brar, Tripti

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | January 13, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.738926639.793590877 Get It

Faculty Opinions recommendation of American Rhinologic Society expert practice statement: Postoperative pain management and opioid use after sinonasal surgery.
Lal, Devyani , Brar, Tripti

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | January 13, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.740463398.793590878 Get It